Abacavir sulfate is a potent HIV-specific agent commonly prescribed in the management of human immunodeficiency virus (HIV) infection. It exerts its action by competitively inhibiting the activity of the viral reverse transcriptase enzyme, thereby preventing the conversion of HIV RNA to DNA. This blockade disrupts the HIV multiplication, leading to